Skip to content
Screener

Enovis ENOV Total Revenue

Total Revenue at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Stryker logo
StrykerSYK
$6.59B+9.4%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$210.93M+3.8%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$2.18B+4.8%
Treace Medical Concepts, Inc. logo
Treace Medical Concepts, Inc.TMCI
$45.38M-4.2%
ESAB logo
ESABESAB
$807.63M+12.9%

Segments

By product

See full
Surgical$294.53M+7.5%
Bracing and Support$127.61M+5.6%
Other Prevention and Recovery$59.64M-15.8%

By segment

See full
Reconstructive$294.53M+7.5%
Prevention & Recovery$288.25M

By geography

See full
United States$1.25B+8.1%

Other financials

Income statement

See full
Gross profit$359.2M+7.3%
Operating income$17.4M+204%
Net income-$1.2M+96.8%
EPS (diluted)-$0.02+96.9%

Balance sheet

See full
Cash & equivalents$12.6M-71.5%
Total debt$1.3B-6.4%
Total equity$1.5B-42.7%
Total assets$3.8B-25.0%

Cash flow

See full
Operating cash flow$75.0M+57.1%
CapEx$43.9M-1.1%
Free cash flow$31.1M

Valuation

See full
Market cap$1.52B+3.1%
Enterprise value$2.81B-0.4%
P/S0.7×0.0×

Profitability

See full
Gross margin61.1%+3.5pp
Operating margin-45.1%+19.4pp
Net margin-48%+17.7pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-54.3%+672pp
Debt / equity0.9×+0.3×
Current ratio-0.3×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Enovis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:45 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001420800-26-000035
Line itemThree Months Ended / July 3, 2026Three Months Ended / July 4, 2025Six Months Ended / July 3, 2026Six Months Ended / July 4, 2025
Net sales$582,782$564,545$1,171,933$1,123,379
Cost of sales223,533229,848447,199456,453
Gross profit359,249334,697724,734666,926
Selling, general and administrative expense263,730267,074546,540536,093
Research and development expense31,68630,70063,21959,228
Amortization of acquired intangibles41,56142,96283,46584,774
Purchase of royalty interest10,04145,818
Restructuring charges4,8597167,5674,578

Item 1. Financial Statements

FAQ

What is Enovis's total revenue?
Enovis (ENOV) reported total revenue of $582.78M in Q2 2026.
How has Enovis's total revenue changed year-over-year?
Enovis's total revenue increased by 3.2% year-over-year, from $564.55M to $582.78M.
What is the long-term trend for Enovis's total revenue?
Over 4 years (2021 to 2025), Enovis's total revenue has grown at a 12.0% compound annual growth rate (CAGR), from $1.43B to $2.25B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Enovis's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude